📈 Live Market Tracking
AI-Powered NSE Corporate Announcements Analysis
Rallis India Appoints Former Mahindra Agri CEO Ashok Sharma as Independent Director for 5 Years
Rallis India has appointed Mr. Ashok Sharma as an Additional Independent Director for a five-year term effective February 10, 2026. Mr. Sharma is a seasoned industry veteran who served as the MD & CEO of Mahindra Agri Solutions Limited from 2011 to 2023. His extensive experience in agri-tech, R&D, and international joint ventures is expected to provide significant strategic value to Rallis. The appointment is subject to shareholder approval and strengthens the board's domain expertise in the agricultural sector.
Key Highlights
Appointment of Mr. Ashok Sharma as Independent Director for a 5-year term until February 9, 2031
Mr. Sharma brings over 30 years of experience, including 26 years at the Mahindra & Mahindra group
Previously served as MD & CEO of Mahindra Agri Solutions for 12 years, focusing on R&D and farm tech
Expertise includes setting up international JVs for agrochemicals and seed businesses
The appointment is based on the recommendation of the Nomination and Remuneration Committee
💼 Action for Investors
Investors should view this as a positive governance move that brings deep sector-specific leadership to the board. Monitor how his expertise in agri-tech and R&D influences the company's long-term product pipeline.
Rallis India Q3 Revenue Up 19% to ₹623 Cr; PAT Impacted by ₹40 Cr Exceptional Wage Provision
Rallis India reported a robust 19% YoY revenue growth to ₹623 crore for Q3 FY26, primarily driven by a 28% increase in volumes despite an 8% decline in realizations. EBITDA grew by 29% to ₹58 crore, but Net Profit (PAT) fell 81% to ₹2 crore due to a one-time ₹40 crore gratuity provision following wage code implementation. The export segment (B2B) was a standout performer, surging 73% YoY, while the seeds business grew 46% despite seasonal headwinds. Management remains focused on digital engagement and new product launches to counter global pricing pressures from China.
Key Highlights
Revenue grew 19% YoY to ₹623 crore, supported by a strong 28% volume expansion.
PAT declined 81% to ₹2 crore due to an exceptional ₹40 crore provision for gratuity.
Export (B2B) revenue surged 73% to ₹129 crore, driven by higher capacity utilization and customer expansion.
Seeds business revenue increased 46% to ₹43 crore, led by paddy, mustard, and wheat placements.
Maintained strong liquidity with cash and liquid balances of ₹455 crore as of December 31, 2025.
💼 Action for Investors
Investors should look past the one-time PAT hit and focus on the strong volume growth and export recovery. Monitor the impact of global pricing volatility and Chinese competition on future margins.
Rallis India Q3 FY26 Revenue Rises 19% to ₹623 Cr; PAT Impacted by One-Off Gratuity Provision
Rallis India reported a 19% YoY revenue growth to ₹623 Cr for Q3 FY26, driven by robust volume growth in Crop Care (27%) and Seeds (50%). While EBITDA grew 29% to ₹58 Cr, reported PAT fell 81% to ₹2 Cr due to a one-time additional gratuity provision arising from the new Wage Code. The B2B export and Custom Synthesis Manufacturing (CSM) segment showed strong momentum with a 56% YoY revenue increase. Despite price degrowth of 9% in Crop Care due to competition, the company's 9M FY26 PAT remains healthy at ₹199 Cr, up 26% YoY.
Key Highlights
Q3 FY26 Revenue increased 19% YoY to ₹623 Cr, while 9M FY26 Revenue grew 9% to ₹2,441 Cr.
B2B Exports including CSM revenue surged by 56% YoY in Q3, driven by customer expansion.
Volume growth of 27% in Crop Care and 50% in Seeds offset price declines of 9% and 3% respectively.
Q3 PAT dropped to ₹2 Cr from ₹11 Cr YoY due to exceptional one-off gratuity provisions.
Launched 9 new products in 9M FY26, including 7 herbicides and 2 fungicides to plug portfolio gaps.
💼 Action for Investors
Investors should look past the one-off PAT decline and focus on the strong volume recovery and export momentum. Monitor the company's ability to manage input cost inflation and the liquidation of elevated channel inventory in the upcoming quarter.
Rallis India Q3 FY26 Revenue Up 19% to ₹623 Cr; PAT Impacted by Exceptional Items
Rallis India reported a strong 19% YoY revenue growth in Q3 FY26, reaching ₹623 crore, driven by robust volume growth across Crop Care and Seeds segments. While EBITDA grew significantly to ₹58 crore, the net profit (PAT) for the quarter was restricted to ₹2 crore due to a one-time exceptional charge for gratuity provisions related to the new Wage Code. For the nine-month period, the company showed resilience with a 26% increase in PAT to ₹199 crore. Innovation remains a key focus, evidenced by new product launches and international patent grants.
Key Highlights
Q3 Revenue grew 19% YoY to ₹623 crore, while 9M Revenue rose 9% to ₹2,441 crore.
Q3 EBITDA increased to ₹58 crore from ₹44 crore, reflecting improved operational efficiency.
9M PAT surged 26% YoY to ₹199 crore, despite a low Q3 PAT of ₹2 crore caused by exceptional items.
Successfully launched Fateh Nxt™ herbicide and secured a US process patent for Mesotrione.
Strong volume traction observed across Crop Care, Seeds, and B2B business segments.
💼 Action for Investors
Investors should look past the low Q3 PAT as it was hit by a one-time regulatory provision; the underlying operational growth and volume expansion are healthy. Monitor the company's ability to maintain margins amidst seasonal fluctuations in the agri-input sector.
Rallis India Q3 Revenue Up 19% to ₹623 Cr; Net Profit Falls 73% Due to ₹40 Cr One-time Charge
Rallis India reported a 19.3% YoY increase in Q3 FY26 revenue to ₹623 crore, showing steady growth in its agri-inputs business. However, Net Profit for the quarter dropped sharply to ₹3 crore from ₹11 crore in the previous year, primarily due to a one-time exceptional charge of ₹40 crore related to the implementation of new Labour Codes. On an operational basis, Profit Before Exceptional Items and Tax nearly doubled to ₹36 crore compared to ₹19 crore in Q3 FY25, indicating improved underlying margins. For the nine-month period ended December 2025, the company remains on a strong footing with a net profit of ₹199 crore, up 26.7% YoY.
Key Highlights
Revenue from operations grew 19.3% YoY to ₹623 crore in Q3 FY26.
Net Profit declined 72.7% YoY to ₹3 crore due to a ₹40 crore exceptional provision for gratuity under new Labour Codes.
Operational Profit (PBT before exceptional items) rose significantly to ₹36 crore from ₹19 crore YoY.
Nine-month (9M FY26) Net Profit stands at ₹199 crore, a 26.7% increase over the ₹157 crore reported in 9M FY25.
Exceptional items for the quarter included a ₹5 crore gain from the sale of flats, partially offsetting the labour code impact.
💼 Action for Investors
Investors should look past the headline profit decline as it was caused by a non-recurring regulatory charge; the underlying operational growth and margin expansion remain healthy. Monitor the company's ability to maintain this revenue momentum in the upcoming quarters given the seasonal nature of the agri-input industry.
Rallis India Appoints Dr. Devender Kumar as Head R&D - Seeds Division
Rallis India Limited has appointed Dr. Devender Kumar as the Head of Research & Development for its Seeds Division, effective July 1, 2026. He will join the company as a designate on January 2, 2026, to facilitate a smooth transition into the Senior Management Personnel role. Dr. Kumar brings over 23 years of specialized experience in plant breeding and product innovation from industry leaders like Bayer Crop Science and Monsanto. This strategic hire is aimed at enhancing the company's breeding ecosystems and product pipeline across major crops like maize, rice, and cotton.
Key Highlights
Dr. Devender Kumar to take over as Head R&D - Seeds Division effective July 1, 2026.
Brings over 23 years of experience in agricultural science, plant breeding, and germplasm development.
Previous leadership experience at Nuziveedu Seeds, Bayer Crop Science, Monsanto, and Mahyco.
Expertise includes genomics, data science, and R&D IT for next-generation breeding ecosystems.
Designated to join the company starting January 2, 2026, for a transition period.
💼 Action for Investors
Investors should view this as a positive long-term move for the company's seed business, though no immediate impact on financials is expected. Monitor the progress of new seed product launches and R&D efficiency improvements starting in late 2026.